NRC Health (NRC)
NASDAQ: NRC · Real-Time Price · USD
16.57
-0.27 (-1.60%)
At close: Apr 29, 2026, 4:00 PM EDT
16.54
-0.03 (-0.18%)
After-hours: Apr 29, 2026, 4:00 PM EDT
NRC Health Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 373 | 425 | 414 | 971 | 921 | 1,056 | Upgrade
|
| Market Cap Growth | 45.70% | 2.70% | -57.35% | 5.49% | -12.84% | -2.20% | Upgrade
|
| Enterprise Value | 432 | 504 | 465 | 992 | 916 | 1,034 | Upgrade
|
| Last Close Price | 16.84 | 18.60 | 16.91 | 37.15 | 33.89 | 36.93 | Upgrade
|
| PE Ratio | 43.73 | 37.66 | 16.71 | 31.36 | 28.96 | 28.20 | Upgrade
|
| Forward PE | - | 34.39 | 34.39 | 34.39 | 34.39 | 34.39 | Upgrade
|
| PS Ratio | 2.57 | 3.10 | 2.90 | 6.54 | 6.07 | 7.14 | Upgrade
|
| PB Ratio | 28.12 | 30.40 | 13.24 | 19.84 | 12.78 | 12.38 | Upgrade
|
| P/TBV Ratio | - | - | - | - | 104.51 | 48.15 | Upgrade
|
| P/FCF Ratio | 20.48 | 27.01 | 21.59 | 43.48 | 34.83 | 25.87 | Upgrade
|
| P/OCF Ratio | 13.23 | 16.08 | 11.96 | 25.48 | 25.38 | 22.79 | Upgrade
|
| PEG Ratio | - | 2.93 | 2.93 | 2.93 | 2.93 | 2.93 | Upgrade
|
| EV/Sales Ratio | 3.12 | 3.67 | 3.25 | 6.67 | 6.05 | 6.99 | Upgrade
|
| EV/EBITDA Ratio | 12.50 | 13.61 | 11.21 | 21.57 | 17.68 | 18.20 | Upgrade
|
| EV/EBIT Ratio | 16.41 | 17.14 | 13.12 | 24.74 | 19.68 | 20.37 | Upgrade
|
| EV/FCF Ratio | 24.81 | 31.99 | 24.25 | 44.40 | 34.67 | 25.32 | Upgrade
|
| Debt / Equity Ratio | 5.78 | 5.74 | 2.06 | 0.80 | 0.33 | 0.34 | Upgrade
|
| Debt / EBITDA Ratio | 2.22 | 2.14 | 1.53 | 0.84 | 0.45 | 0.50 | Upgrade
|
| Debt / FCF Ratio | 4.48 | 5.10 | 3.36 | 1.74 | 0.89 | 0.70 | Upgrade
|
| Net Debt / Equity Ratio | 5.59 | 5.44 | 1.92 | 0.66 | -0.02 | -0.30 | Upgrade
|
| Net Debt / EBITDA Ratio | 2.18 | 2.06 | 1.45 | 0.70 | -0.03 | -0.45 | Upgrade
|
| Net Debt / FCF Ratio | 4.33 | 4.83 | 3.14 | 1.45 | -0.06 | -0.63 | Upgrade
|
| Asset Turnover | 1.03 | 1.03 | 1.12 | 1.18 | 1.05 | 1.02 | Upgrade
|
| Quick Ratio | 0.35 | 0.43 | 0.44 | 0.53 | 1.21 | 1.71 | Upgrade
|
| Current Ratio | 0.52 | 0.55 | 0.55 | 0.67 | 1.31 | 1.83 | Upgrade
|
| Return on Equity (ROE) | 41.86% | 51.24% | 61.77% | 51.20% | 40.41% | 50.07% | Upgrade
|
| Return on Assets (ROA) | 12.21% | 13.73% | 17.38% | 19.81% | 20.21% | 21.80% | Upgrade
|
| Return on Invested Capital (ROIC) | 18.34% | 21.04% | 31.12% | 40.97% | 53.18% | 63.83% | Upgrade
|
| Return on Capital Employed (ROCE) | 27.40% | 29.90% | 36.70% | 46.50% | 48.00% | 43.30% | Upgrade
|
| Earnings Yield | 2.44% | 2.73% | 5.99% | 3.19% | 3.45% | 3.55% | Upgrade
|
| FCF Yield | 4.88% | 3.70% | 4.63% | 2.30% | 2.87% | 3.87% | Upgrade
|
| Dividend Yield | 3.92% | 2.80% | 2.84% | 1.29% | 2.48% | 1.30% | Upgrade
|
| Payout Ratio | 112.00% | 94.64% | 46.21% | 117.42% | 65.92% | 24.45% | Upgrade
|
| Buyback Yield / Dilution | 5.81% | 5.67% | 3.77% | 1.51% | 2.29% | 0.22% | Upgrade
|
| Total Shareholder Return | 9.81% | 8.47% | 6.61% | 2.80% | 4.77% | 1.52% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.